Browsing by Author Bao, Li

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 22 next >
Issue Date Title Author(s)
Mar-2022 Amp 1q21 is more predictable with dismal survival than gain 1q21 of newly diagnosed multiple myeloma in real-world analysis Wang, Yu-Tong;Bao, Li;Chu, Bin;Chen, Xiao-Huan;Lu, Min-Qiu;Shi, Lei;Gao, Shan;Fang, Li-Juan;Xiang, Qiu-Qing;Ding, Yue-Hua
2013 CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation Zhu, Hong-Hu;Liu, Yan-Rong;Jiang, Hao;Lu, Jin;Qin, Ya-Zhen;Jiang, Qian;Bao, Li;Ruan, Guo-Rui;Jiang, Bin;Huang, Xiaojun
10-Mar-2023 Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study Wang, Yu-tong;Chu, Bin;Zhou, Tian-guan;Lu, Min-qiu;Shi, Lei;Gao, Shan;Fang, Li-juan;Xiang, Qiu-qing;Zhao, Xin-;Wang, Meng-zhen;Sun, Kai;Bao, Li
2014 The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma Zhang, Yao;Bao, Li;Lu, Jin;Liu, Kai-Yan;Li, Jin-Lan;Qin, Ya-Zhen;Chen, Huan;Li, Ling-Di;Kong, Yuan;Shi, Hong-Xia;Lai, Yue-Yun;Liu, Yan-Rong;Jiang, Bin;Chen, Shan-Shan;Huang, Xiao-Jun;Ruan, Guo-Rui
2013 CXCR4 is a good survival prognostic indicator in multiple myeloma patients Bao, Li;Lai, Yueyun;Liu, Yanrong;Qin, Yazhen;Zhao, Xiaosu;Lu, Xijing;Jiang, Qian;Lu, Jin;Huang, Xiaojun
2013 Cytarabine, aclarubicin and granulocyte colony-stimulating factor regimen represents an effective and safe salvage regimen for patients with acute myeloid leukemia refractory to first course of induction chemotherapy Zhu, Hong-Hu;Jiang, Hao;Jiang, Bin;Lu, Jin;Jiang, Qian;Bao, Li;Zhang, Xiao-Hui;Qin, Ya-Zhen;Huang, Xiao-Jun
2014 Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing Yu, Chang;Yu, Jun;Yao, Xiaotian;Wu, William K. K.;Lu, Youyong;Tang, Senwei;Li, Xiangchun;Bao, Li;Li, Xiaoxing;Hou, Yong;Wu, Renhua;Jian, Min;Chen, Ruoyan;Zhang, Fan;Xu, Lixia;Fan, Fan;He, Jun;Liang, Qiaoyi;Wang, Hongyi;Hu, Xueda;He, Minghui;Zhang, Xiang;Zheng, Hancheng;Li, Qibin;Wu, Hanjie;Chen, Yan;Yang, Xu;Zhu, Shida;Xu, Xun;Yang, Huanming;Wang, Jian;Zhang, Xiuqing;Sung, Joseph J. Y.;Li, Yingrui;Wang, Jun
2009 Effects of Pithecellobium clypearia Benth extract and its main components on inflammation and allergy Bao, Li;Yao, Xinsheng;Xu, Jiekun;Guo, Xiaoyu;Liu, Hongwei;Kurihara, Hiroshi
Oct-2021 Efficacy and safety of induction therapy with IAd versus IRd regimen in fragile elderly patients with newly diagnosed multiple myeloma: results of a prospective multicenter clinical trail Bao, Li;Lu, Minqiu;Liu, Peng;Zhuang, Junling;Zhang, Mei;Xia, Zhongjun;Li, Zhenling;Jing, Hongmei;Wu, Yin;Chen, Wen Ming;Zhou, Hebing;Gong, Yuping;Fu, Rong;Yan, Zhenyu;Huang, Wenrong;Chu, Bin;Wang, Yutong;Zhang, Yongqing
15-Nov-2022 Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score >= 2: A Prospective Multicenter Study Bao, Li;Lu, Min-qiu;Liu, Peng;Wang, Yu-Tong;Zhuang, Junling;Zhang, Mei;Xia, Zhongjun;Li, Zhenling;Yang, Ying;Yan, Zhenyu;Jing, Hongmei;Chen, Wenming;Zhou, Hebing;Fu, Rong;Gong, Yuping;Huang, Wenrong;Zhang, Yongqing
30-Jun-2022 Machine Learning-Based Overall Survival Prediction of Elderly Patients With Multiple Myeloma From Multicentre Real-Life Data Bao, Li;Wang, Yu-tong;Zhuang, Jun-ling;Liu, Ai-jun;Dong, Yu-jun;Chu, Bin;Chen, Xiao-huan;Lu, Min-qiu;Shi, Lei;Gao, Shan;Fang, Li-juan;Xiang, Qiu-qing;Ding, Yue-hua
2013 MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial Zhu, Hong-Hu;Zhang, Xiao-Hui;Qin, Ya-Zhen;Liu, Dai-Hong;Jiang, Hao;Chen, Huan;Jiang, Qian;Xu, Lan-Ping;Lu, Jin;Han, Wei;Bao, Li;Wang, Yu;Chen, Yu-Hong;Wang, Jing-Zhi;Wang, Feng-Rong;Lai, Yue-Yun;Chai, Jun-Yue;Wang, Li-Ru;Liu, Yan-Rong;Liu, Kai-Yan;Jiang, Bin;Huang, Xiao-Jun
15-Nov-2022 Renal Response of Pomalidomide with Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study Jian, Yuan;Chang, Long;Shi, Mingxia;Sun, Ying;Chu, Xiaoxia;Xue, Hua;Huang, Wenrong;Shen, Xuliang;Ma, Jie;Jia, Guorong;Peng, Yaqing;Xi, Zhenfang;Zhao, Yanhong;Ma, Yanping;Xiao, Jing;Ma, Guangyu;Wang, Qingming;Bao, Li;Dong, Yujun;Zhou, Hebing;Sun, Chunyan;Su, Guohong;Yan, Yan;Qimuge, Saiyin;Su, Liping;Sun, Jingnan;Tian, Weiwei;Sun, Xiuli;Jing, Hongmei;Gao, Da;Chen, Wenming;Li, Jian;Gao, Wen
2014 Reversibility of Renal Insufficiency in Patients with Newly Diagnosed Multiple Myeloma and the Role of different induction Regimens Bao, Li;Lu, Jin;Huang, Xiaojun
2012 Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor Xu, Xun;Hou, Yong;Yin, Xuyang;Bao, Li;Tang, Aifa;Song, Luting;Li, Fuqiang;Tsang, Shirley;Wu, Kui;Wu, Hanjie;He, Weiming;Zeng, Liang;Xing, Manjie;Wu, Renhua;Jiang, Hui;Liu, Xiao;Cao, Dandan;Guo, Guangwu;Hu, Xueda;Gui, Yaoting;Li, Zesong;Xie, Wenyue;Sun, Xiaojuan;Shi, Min;Cai, Zhiming;Wang, Bin;Zhong, Meiming;Li, Jingxiang;Lu, Zuhong;Gu, Ning;Zhang, Xiuqing;Goodman, Laurie;Bolund, Lars;Wang, Jian;Yang, Huanming;Kristiansen, Karsten;Dean, Michael;Li, Yingrui;Wang, Jun
26-Jan-2022 SRSF1 Deficiency Impairs the Late Thymocyte Maturation and the CD8 Single-Positive Lineage Fate Decision Ji, Ce;Bao, Li;Yuan, Shunzong;Qi, Zhihong;Wang, Fang;You, Menghao;Yu, Guotao;Liu, Jingjing;Cui, Xiao;Wang, Zhao;Liu, Juanjuan;Guo, Wenhui;Feng, Mingxia;Chen, Feng;Kang, Youmin;Yu, Shuyang
2016 Superior myeloma response with bortezomib-based regimen in multiple myeloma patients with renal impairment Bao, Li;Lu, Jin;Wang, Shihua;Huang, Xiaojun
23-Jun-2022 Toward Therapeutic Drug Monitoring of Lenalidomide in Hematological Malignancy? Results of an Observational Study of the Exposure-Safety Relationship Song, Zaiwei;Ma, Lan;Bao, Li;Ma, Yi;Yang, Ping;Jiang, Dan;Liu, Aijun;Zhang, Lu;Li, Yan;Cheng, Yinchu;Dong, Fei;Zhao, Rongsheng;Jing, Hongmei
2014 Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-trans retinoic acid and arsenic compound-based combined therapies Lu, Jin;Huang, Xiaojun;Bao, Li;Jiang, Hao;Zhu, Honghu;Jiang, Bin
23-Nov-2021 Trial in Progress: A Perspective Study of Pan-Oral Triplet Regimen Pomalidomide, Ixazomib and Dexamethasone in Relapsed or Refractory Myeloma Patients Chen, Miao;Bao, Li;Chen, Wenming;Fu, Rong;Guo, Rong;Jing, Hongmei;Liu, Hui;Liu, Qinhua;Ma, Yanping;Sun, Xiuli;Wang, Wei;Wang, Yafei;Yan, Xiaojing;Qian, Jiang;Zhuang, Junling
Showing results 1 to 20 of 22 next >